EGFR Inhibitor: What It Is and How It Works
EGFR inhibitors are medicines that block a protein called the epidermal growth factor receptor. That protein helps some cancer cells grow fast. By stopping the receptor, the drugs slow down or stop tumor growth. They're a big part of targeted therapy, which means they focus on a specific weakness in the cancer instead of attacking the whole body.
Common EGFR Inhibitor Drugs
Doctors prescribe several EGFR blockers, each with its own name and dosing schedule. The most well‑known ones are erlotinib (Tarceva), gefitinib (Iressa), afatinib (Gilotrif), osimertinib (Tagrisso), and lapatinib (Tykerb). Some are taken once a day, others twice, and a few need to be taken with food. Your doctor will pick the right one based on the cancer type, genetic tests, and how your body handles the drug.
When you start an EGFR inhibitor, the doctor will run blood tests and imaging scans. These checks help see if the medicine is working and if any side effects need attention. If a test shows the tumor is shrinking, you’ll likely keep the same dose. If it isn’t, the doctor might switch drugs or add another treatment.
Managing Side Effects
Side effects are common, but most are manageable. The most frequent ones are skin rash, diarrhea, and nausea. A mild rash usually appears on the face or chest; keep the skin clean, use gentle moisturizers, and avoid harsh soaps. For diarrhea, stay hydrated, eat small frequent meals, and talk to your doctor about anti‑diarrheal meds.
Some people also feel tired or have a loss of appetite. Keeping a balanced diet, getting enough rest, and light exercise can make a difference. If you notice any new or worsening symptoms—like fever, severe coughing, or vision changes—call your healthcare team right away.
Drug interactions matter, too. Avoid taking green tea extracts, St. John’s wort, or certain antibiotics without checking with your pharmacist. These can change how the EGFR inhibitor works and raise the risk of side effects.
Because EGFR inhibitors affect the liver, regular liver function tests are a must. If the tests show high enzyme levels, your doctor may lower the dose or pause treatment temporarily. Never change the dose on your own.
Staying organized helps a lot. Use a pill organizer, set phone reminders, and keep a simple diary of any side effects you experience. This way, you can share accurate information with your doctor at each visit.
Finally, remember you’re not alone. Many cancer centers offer support groups for people on targeted therapies. Talking with others who understand the daily challenges can provide emotional boost and practical tips.
In short, EGFR inhibitors are powerful tools that can turn a tough diagnosis into a manageable condition. Knowing how they work, what side effects to expect, and how to handle them puts you in control of your treatment journey.
Erlotinib for Refractory Cancer: 2025 Clinical Review
A detailed 2025 review of erlotinib use in refractory cancers, covering mechanism, key trials, dosing, safety, and future directions for oncologists.